Literature DB >> 24943346

Baló's concentric sclerosis.

Todd A Hardy1, David H Miller2.   

Abstract

Baló's concentric sclerosis is often regarded as a rare variant of multiple sclerosis. Patients with this disorder present with acute or subacute neurological deterioration, with MRI showing one or more concentrically multilayered ring-like lesions usually in the cerebral white matter. Historically, Baló's concentric sclerosis was thought fatal in all cases. However, the availability of MRI has led to a better appreciation of the variable natural history of patients presenting with radiologically evident Baló lesions and the clinical association with multiple sclerosis and, less often, with other neurological disorders. Important advances have increased understanding of the immunopathogenic mechanisms associated with the formation of Baló lesions. However, how to treat an acute lesion and when or whether to start treatment are less well understood, although for patients with Baló lesions who also fulfil standard diagnostic criteria for multiple sclerosis, our opinion is that treatment with multiple sclerosis disease-modifying therapy would seem reasonable.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24943346     DOI: 10.1016/S1474-4422(14)70052-3

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  20 in total

Review 1.  Differential imaging of atypical demyelinating lesions of the central nervous system.

Authors:  Matteo Paoletti; Shaun Ivan Muzic; Francesca Marchetti; Lisa Maria Farina; Stefano Bastianello; Anna Pichiecchio
Journal:  Radiol Med       Date:  2021-01-24       Impact factor: 3.469

2.  [Inflammatory diseases of the central nervous system].

Authors:  Armin Bachhuber
Journal:  Radiologe       Date:  2021-06-08       Impact factor: 0.635

3.  Balo concentric sclerosis in a 23-year-old man.

Authors:  Yi-Chien Yang; Chon-Haw Tsai
Journal:  CMAJ       Date:  2018-08-07       Impact factor: 8.262

4.  The "central vein sign" in patients with diagnostic "red flags" for multiple sclerosis: A prospective multicenter 3T study.

Authors:  Pietro Maggi; Martina Absinta; Pascal Sati; Gaetano Perrotta; Luca Massacesi; Bernard Dachy; Caroline Pot; Reto Meuli; Daniel S Reich; Massimo Filippi; Renaud Du Pasquier; Marie Théaudin
Journal:  Mult Scler       Date:  2019-09-19       Impact factor: 6.312

5.  Balò's concentric sclerosis: still to be considered as a variant of multiple sclerosis?

Authors:  Anna M Pietroboni; Andrea Arighi; Milena A De Riz; Laura Ghezzi; Alberto Calvi; Sabrina Avignone; Elisa Scola; Daniela Galimberti; Fabio Triulzi; Elio Scarpini
Journal:  Neurol Sci       Date:  2015-06-25       Impact factor: 3.307

6.  Isolation of Astrocytes Displaying Myofibroblast Properties and Present in Multiple Sclerosis Lesions.

Authors:  Nicolas Vedrenne; Vincent Sarrazy; Laurence Richard; Nelly Bordeau; Serge Battu; Fabrice Billet; Alexis Desmoulière
Journal:  Neurochem Res       Date:  2017-04-22       Impact factor: 3.996

Review 7.  Tumefactive Demyelinating Lesions in Multiple Sclerosis and Associated Disorders.

Authors:  Meredith C Frederick; Michelle H Cameron
Journal:  Curr Neurol Neurosci Rep       Date:  2016-03       Impact factor: 5.081

8.  Clinical and Radiologic Features, Pathology, and Treatment of Baló Concentric Sclerosis.

Authors:  Evan A Jolliffe; Yong Guo; Todd A Hardy; P Pearse Morris; Eoin P Flanagan; Claudia F Lucchinetti; W Oliver Tobin
Journal:  Neurology       Date:  2021-05-19       Impact factor: 11.800

9.  Balo's concentric lesions with concurrent features of Schilder's disease in relapsing multiple sclerosis: neuropathological findings.

Authors:  Maher Kurdi; David Ramsay
Journal:  Autops Case Rep       Date:  2016-12-30

10.  Baló's concentric sclerosis is immunologically distinct from multiple sclerosis: results from retrospective analysis of almost 150 lumbar punctures.

Authors:  S Jarius; C Würthwein; J R Behrens; J Wanner; J Haas; F Paul; B Wildemann
Journal:  J Neuroinflammation       Date:  2018-01-18       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.